GlobeStar Therapeutics Corporation
GSTC · OTC
9/30/2023 | 9/30/2022 | 9/30/2021 | 9/30/2020 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $0 | $6 | $6 | $81 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $2 |
| Other Curr. Assets | $0 | $4 | $0 | $5 |
| Total Curr. Assets | $0 | $10 | $6 | $89 |
| Property Plant & Equip (Net) | $0 | $0 | $0 | $1 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $0 | $0 | $0 | $1 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $0 | $10 | $6 | $90 |
| Liabilities | – | – | – | – |
| Payables | $328 | $381 | $223 | $133 |
| Short-Term Debt | $366 | $20 | $106 | $155 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $740 | $804 | $403 | $461 |
| Total Curr. Liab. | $1,434 | $1,204 | $732 | $749 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $0 | $0 | $329 | $289 |
| Other Liabilities | $0 | -$1 | -$329 | -$289 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $1,434 | $1,204 | $732 | $749 |
| Equity | – | – | – | – |
| Pref Stock | $1 | $2 | $2 | $2 |
| Common Stock | $996 | $722 | $561 | $436 |
| Retained Earnings | -$20,454 | -$18,505 | -$17,017 | -$7,215 |
| AOCI | $0 | $5 | $500 | $0 |
| Other Equity | $18,023 | $16,581 | $15,228 | $6,118 |
| Total Equity | -$1,434 | -$1,195 | -$726 | -$659 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $0 | $10 | $6 | $90 |
| Net Debt | $366 | $14 | $100 | $74 |